118 related articles for article (PubMed ID: 3756765)
21. Malignant obstructive jaundice: treatment with external-beam and intracavitary radiotherapy.
Johnson DW; Safai C; Goffinet DR
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):411-6. PubMed ID: 2579052
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
23. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
24. Combined isodose curves of high-dose rate interstitial brachytherapy with external-beam radiation therapy in pancreatic carcinoma.
Warszawski N; Pfreundner L; Bratengeier K; Bohndorf W; Feustel H
Strahlenther Onkol; 1992 Sep; 168(9):552-7. PubMed ID: 1384154
[TBL] [Abstract][Full Text] [Related]
25. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
[TBL] [Abstract][Full Text] [Related]
26. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
[TBL] [Abstract][Full Text] [Related]
27. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group.
Ann Surg; 1979 Feb; 189(2):205-8. PubMed ID: 426553
[TBL] [Abstract][Full Text] [Related]
28. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
[TBL] [Abstract][Full Text] [Related]
29. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
Schleicher UM; Staatz G; Alzen G; Andreopoulos D
Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy.
Takácsi-Nagy Z; Varga J; Poller I; Fodor J; Polgár C; Petrányi A; Major T; Németh G
Hepatogastroenterology; 2002; 49(45):844-6. PubMed ID: 12064004
[TBL] [Abstract][Full Text] [Related]
31. Treatment of cancer of the pancreas by precision high dose (PHD) external photon beam and intraoperative electron beam therapy (IOEBT).
Dobelbower RR; Howard JM; Bagne FR; Eltaki A; Merrick HW
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):205-9. PubMed ID: 2463978
[TBL] [Abstract][Full Text] [Related]
32. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
33. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.
Flickinger JC; Epstein AH; Iwatsuki S; Carr BI; Starzl TE
Cancer; 1991 Jul; 68(2):289-94. PubMed ID: 2070327
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.
Sanz-Altamira PM; Ferrante K; Jenkins RL; Lewis WD; Huberman MS; Stuart KE
Cancer; 1998 Jun; 82(12):2321-5. PubMed ID: 9635523
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
Mohiuddin M; Rosato F; Barbot D; Schuricht A; Biermann W; Cantor R
Int J Radiat Oncol Biol Phys; 1992; 23(2):305-11. PubMed ID: 1587751
[TBL] [Abstract][Full Text] [Related]
37. Interstitial brachytherapy for pancreatic cancer: report of seven cases treated with 125I and a review of the literature.
Montemaggi P; Dobelbower R; Crucitti F; Caracciolo F; Morganti AG; Smaniotto D; Luzi S; Cellini N
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):451-7. PubMed ID: 2061121
[TBL] [Abstract][Full Text] [Related]
38. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Spitz FR; Abbruzzese JL; Lee JE; Pisters PW; Lowy AM; Fenoglio CJ; Cleary KR; Janjan NA; Goswitz MS; Rich TA; Evans DB
J Clin Oncol; 1997 Mar; 15(3):928-37. PubMed ID: 9060530
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
[TBL] [Abstract][Full Text] [Related]
40. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
Klaassen DJ; MacIntyre JM; Catton GE; Engstrom PF; Moertel CG
J Clin Oncol; 1985 Mar; 3(3):373-8. PubMed ID: 3973648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
